Sex-dependent differences in renal angiotensinogen as an early marker of diabetic nephropathy

Acta Physiol (Oxf). 2015 Mar;213(3):740-6. doi: 10.1111/apha.12441. Epub 2015 Jan 2.

Abstract

Aim: The renal renin-angiotensin system (RAS) has been implicated in the pathogenesis of diabetic nephropathy. The aim of this study was to investigate sex differences in renal renin-angiotensin system (RAS) and the roles of androgens in diabetes-associated renal injury.

Methods: Renal injury and fibrosis were studied in streptozotocin-induced diabetic rats by albuminuria and by gene expression of collagen I and fibronectin. RAS was investigated by analysing the plasma angiotensinogen (AOGEN) and renin activity (PRA) and their renal gene expression. Also, a group of diabetic rats was treated with the anti-androgen flutamide.

Results: Albuminuria was significantly lower in diabetic females than in males (1.2 [0.8-1.5] versus 4.4 [2.2-6.1] mg/24 h, data are median [IQR] values, P < 0.05). Renal AOGEN mRNA levels were increased by diabetes in males (8.1 ± 0.8% in diabetes versus 0.8 ± 0.2% in control, P < 0.001) but not in females (1.0 ± 0.1% in diabetes versus 0.8 ± 0.1% in control, P > 0.05), as were collagen I and fibronectin mRNAs. Furthermore, AOGEN mRNA levels were strongly correlated with albuminuria (Spearman r = 0.64, 95% [CI] 0.36-0.81, P < 0.0001). Diabetes decreased PRA, renal renin mRNA and plasma AOGEN in both females and males. Anti-androgen treatment decreased albuminuria only in diabetic males without affecting the endocrine or renal RAS.

Conclusions: These data indicate that renal but not hepatic AOGEN or renin is positively associated with diabetic albuminuria and contribute to the sex-dependent differences in renal injury. Androgens may contribute to albuminuria in male independently of the RAS.

Keywords: albuminuria; androgens; diabetes; renal angiotensinogen; sexual dimorphism.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Albuminuria / blood
  • Albuminuria / etiology
  • Androgen Antagonists / pharmacology
  • Angiotensinogen / blood*
  • Angiotensinogen / genetics
  • Animals
  • Biomarkers / blood
  • Collagen Type I / genetics
  • Collagen Type I / metabolism
  • Diabetes Mellitus, Experimental / blood
  • Diabetes Mellitus, Experimental / complications*
  • Diabetic Nephropathies / blood
  • Diabetic Nephropathies / etiology*
  • Diabetic Nephropathies / genetics
  • Diabetic Nephropathies / pathology
  • Female
  • Fibronectins / genetics
  • Fibronectins / metabolism
  • Fibrosis
  • Flutamide / pharmacology
  • Kidney / drug effects
  • Kidney / metabolism*
  • Kidney / pathology
  • Male
  • RNA, Messenger / metabolism
  • Rats, Sprague-Dawley
  • Renin / blood
  • Renin / genetics
  • Renin-Angiotensin System* / drug effects
  • Renin-Angiotensin System* / genetics
  • Risk Factors
  • Sex Factors

Substances

  • Androgen Antagonists
  • Biomarkers
  • Collagen Type I
  • Fibronectins
  • RNA, Messenger
  • Angiotensinogen
  • Flutamide
  • Renin